1	1	_	_	CD	_	_	_	_	_
2	.	_	_	.	_	_	_	_	_


1	Introduction	_	_	NN	_	_	_	_	_


1	Obesity	_	_	NN	_	_	_	_	_
2	and	_	_	CC	_	_	_	_	_
3	vitamin-D	_	_	NN	_	_	_	_	_
4	deficiency	_	_	NN	_	_	_	_	_
5	are	_	_	VBP	_	_	_	_	_
6	two	_	_	CD	_	_	_	_	_
7	major	_	_	JJ	_	_	_	_	_
8	global	_	_	JJ	_	_	_	_	_
9	public	_	_	JJ	_	_	_	_	_
10	health	_	_	NN	_	_	_	_	_
11	concerns	_	_	NNS	_	_	_	_	_
12	that	_	_	WDT	_	_	_	_	_
13	affect	_	_	VBP	_	_	_	_	_
14	over	_	_	IN	_	_	_	_	_
15	one-third	_	_	NN	_	_	_	_	_
16	of	_	_	IN	_	_	_	_	_
17	the	_	_	DT	_	_	_	_	_
18	population	_	_	NN	_	_	_	_	_
19	.	_	_	.	_	_	_	_	_


1	A	_	_	DT	_	_	_	_	_
2	body	_	_	NN	_	_	_	_	_
3	mass	_	_	NN	_	_	_	_	_
4	index	_	_	NN	_	_	_	_	_
5	of	_	_	IN	_	_	_	_	_
6	more	_	_	JJR	_	_	_	_	_
7	than	_	_	IN	_	_	_	_	_
8	30	_	_	CD	_	_	_	_	_
9	kg/m2	_	_	NN	_	_	_	_	_
10	is	_	_	VBZ	_	_	_	_	_
11	associated	_	_	VBN	_	_	_	_	_
12	with	_	_	IN	_	_	_	_	_
13	lower	_	_	JJR	_	_	_	_	_
14	serum	_	_	NN	_	_	_	_	_
15	vitamin-D	_	_	NN	_	_	_	_	_
16	levels	_	_	NNS	_	_	_	_	_
17	compared	_	_	VBN	_	_	_	_	_
18	with	_	_	IN	_	_	_	_	_
19	non-obese	_	_	JJ	_	_	_	_	_
20	individuals	_	_	NNS	_	_	_	_	_
21	.	_	_	.	_	_	_	_	_


1	Several	_	_	JJ	_	_	_	_	_
2	mechanisms	_	_	NNS	_	_	_	_	_
3	that	_	_	WDT	_	_	_	_	_
4	contribute	_	_	VBP	_	_	_	_	_
5	to	_	_	TO	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	high	_	_	JJ	_	_	_	_	_
8	incidence	_	_	NN	_	_	_	_	_
9	of	_	_	IN	_	_	_	_	_
10	vitamin-D	_	_	NN	_	_	_	_	_
11	deficiency	_	_	NN	_	_	_	_	_
12	in	_	_	IN	_	_	_	_	_
13	obese	_	_	JJ	_	_	_	_	_
14	people	_	_	NNS	_	_	_	_	_
15	were	_	_	VBD	_	_	_	_	_
16	suggested	_	_	VBN	_	_	_	_	_
17	.	_	_	.	_	_	_	_	_


1	Ultraviolet	_	_	JJ	_	_	_	_	_
2	radiation	_	_	NN	_	_	_	_	_
3	from	_	_	IN	_	_	_	_	_
4	sunlight	_	_	NN	_	_	_	_	_
5	exposure	_	_	NN	_	_	_	_	_
6	is	_	_	VBZ	_	_	_	_	_
7	required	_	_	VBN	_	_	_	_	_
8	for	_	_	IN	_	_	_	_	_
9	cutaneous	_	_	JJ	_	_	_	_	_
10	production	_	_	NN	_	_	_	_	_
11	of	_	_	IN	_	_	_	_	_
12	vitamin	_	_	NN	_	_	_	_	_
13	D.	_	_	NNP	_	_	_	_	_
14	It	_	_	PRP	_	_	_	_	_
15	was	_	_	VBD	_	_	_	_	_
16	proposed	_	_	VBN	_	_	_	_	_
17	that	_	_	IN	_	_	_	_	_
18	obese	_	_	JJ	_	_	_	_	_
19	individuals	_	_	NNS	_	_	_	_	_
20	,	_	_	,	_	_	_	_	_
21	overall	_	_	RB	_	_	_	_	_
22	,	_	_	,	_	_	_	_	_
23	have	_	_	VBP	_	_	_	_	_
24	suboptimal	_	_	JJ	_	_	_	_	_
25	levels	_	_	NNS	_	_	_	_	_
26	of	_	_	IN	_	_	_	_	_
27	vitamin	_	_	NN	_	_	_	_	_
28	D	_	_	NN	_	_	_	_	_
29	because	_	_	IN	_	_	_	_	_
30	they	_	_	PRP	_	_	_	_	_
31	tend	_	_	VBP	_	_	_	_	_
32	to	_	_	TO	_	_	_	_	_
33	participate	_	_	VB	_	_	_	_	_
34	in	_	_	IN	_	_	_	_	_
35	fewer	_	_	JJR	_	_	_	_	_
36	outdoor	_	_	JJ	_	_	_	_	_
37	activities	_	_	NNS	_	_	_	_	_
38	and	_	_	CC	_	_	_	_	_
39	,	_	_	,	_	_	_	_	_
40	accordingly	_	_	RB	_	_	_	_	_
41	,	_	_	,	_	_	_	_	_
42	have	_	_	VB	_	_	_	_	_
43	less	_	_	JJR	_	_	_	_	_
44	exposure	_	_	NN	_	_	_	_	_
45	to	_	_	TO	_	_	_	_	_
46	sunlight	_	_	NN	_	_	_	_	_
47	.	_	_	.	_	_	_	_	_


1	Vitamin	_	_	NNP	_	_	_	_	_
2	D	_	_	NNP	_	_	_	_	_
3	is	_	_	VBZ	_	_	_	_	_
4	a	_	_	DT	_	_	_	_	_
5	lipid-soluble	_	_	JJ	_	_	_	_	_
6	vitamin	_	_	NN	_	_	_	_	_
7	,	_	_	,	_	_	_	_	_
8	and	_	_	CC	_	_	_	_	_
9	it	_	_	PRP	_	_	_	_	_
10	is	_	_	VBZ	_	_	_	_	_
11	thought	_	_	VBN	_	_	_	_	_
12	that	_	_	IN	_	_	_	_	_
13	the	_	_	DT	_	_	_	_	_
14	lower	_	_	JJR	_	_	_	_	_
15	bioavailability	_	_	NN	_	_	_	_	_
16	of	_	_	IN	_	_	_	_	_
17	vitamin	_	_	NN	_	_	_	_	_
18	D	_	_	NN	_	_	_	_	_
19	in	_	_	IN	_	_	_	_	_
20	obese	_	_	JJ	_	_	_	_	_
21	individuals	_	_	NNS	_	_	_	_	_
22	,	_	_	,	_	_	_	_	_
23	compared	_	_	VBN	_	_	_	_	_
24	to	_	_	TO	_	_	_	_	_
25	lean	_	_	JJ	_	_	_	_	_
26	individuals	_	_	NNS	_	_	_	_	_
27	,	_	_	,	_	_	_	_	_
28	is	_	_	VBZ	_	_	_	_	_
29	due	_	_	JJ	_	_	_	_	_
30	to	_	_	TO	_	_	_	_	_
31	vitamin-D	_	_	NN	_	_	_	_	_
32	sequestration	_	_	NN	_	_	_	_	_
33	within	_	_	IN	_	_	_	_	_
34	the	_	_	DT	_	_	_	_	_
35	adipose	_	_	NN	_	_	_	_	_
36	tissues	_	_	NNS	_	_	_	_	_
37	.	_	_	.	_	_	_	_	_


1	Lastly	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	vitamin-D	_	_	NN	_	_	_	_	_
4	deficiency	_	_	NN	_	_	_	_	_
5	may	_	_	MD	_	_	_	_	_
6	also	_	_	RB	_	_	_	_	_
7	be	_	_	VB	_	_	_	_	_
8	due	_	_	JJ	_	_	_	_	_
9	to	_	_	TO	_	_	_	_	_
10	inadequate	_	_	JJ	_	_	_	_	_
11	dietary	_	_	JJ	_	_	_	_	_
12	intake	_	_	NN	_	_	_	_	_
13	or	_	_	CC	_	_	_	_	_
14	malabsorption	_	_	NN	_	_	_	_	_
15	of	_	_	IN	_	_	_	_	_
16	vitamin	_	_	NN	_	_	_	_	_
17	D.	_	_	NNP	_	_	_	_	_
18	Obesity	_	_	NNP	_	_	_	_	_
19	is	_	_	VBZ	_	_	_	_	_
20	a	_	_	DT	_	_	_	_	_
21	well-established	_	_	JJ	_	_	_	_	_
22	risk	_	_	NN	_	_	_	_	_
23	factor	_	_	NN	_	_	_	_	_
24	for	_	_	IN	_	_	_	_	_
25	the	_	_	DT	_	_	_	_	_
26	development	_	_	NN	_	_	_	_	_
27	of	_	_	IN	_	_	_	_	_
28	cardiovascular	_	_	JJ	_	_	_	_	_
29	disease	_	_	NN	_	_	_	_	_
30	(	_	_	-LRB-	_	_	_	_	_
31	CVD	_	_	NN	_	_	_	_	_
32	)	_	_	-RRB-	_	_	_	_	_
33	,	_	_	,	_	_	_	_	_
34	and	_	_	CC	_	_	_	_	_
35	several	_	_	JJ	_	_	_	_	_
36	mechanisms	_	_	NNS	_	_	_	_	_
37	may	_	_	MD	_	_	_	_	_
38	contribute	_	_	VB	_	_	_	_	_
39	to	_	_	TO	_	_	_	_	_
40	this	_	_	DT	_	_	_	_	_
41	link	_	_	NN	_	_	_	_	_
42	.	_	_	.	_	_	_	_	_


1	However	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	a	_	_	DT	_	_	_	_	_
4	role	_	_	NN	_	_	_	_	_
5	of	_	_	IN	_	_	_	_	_
6	vitamin-D	_	_	NN	_	_	_	_	_
7	deficiency	_	_	NN	_	_	_	_	_
8	in	_	_	IN	_	_	_	_	_
9	obesity-associated	_	_	JJ	_	_	_	_	_
10	cardiovascular	_	_	JJ	_	_	_	_	_
11	(	_	_	-LRB-	_	_	_	_	_
12	CV	_	_	NN	_	_	_	_	_
13	)	_	_	-RRB-	_	_	_	_	_
14	risk	_	_	NN	_	_	_	_	_
15	is	_	_	VBZ	_	_	_	_	_
16	yet	_	_	RB	_	_	_	_	_
17	to	_	_	TO	_	_	_	_	_
18	be	_	_	VB	_	_	_	_	_
19	established	_	_	VBN	_	_	_	_	_
20	.	_	_	.	_	_	_	_	_


1	Epidemiological	_	_	JJ	_	_	_	_	_
2	data	_	_	NNS	_	_	_	_	_
3	reported	_	_	VBD	_	_	_	_	_
4	associations	_	_	NNS	_	_	_	_	_
5	between	_	_	IN	_	_	_	_	_
6	vitamin	_	_	NN	_	_	_	_	_
7	D	_	_	NN	_	_	_	_	_
8	deficiency	_	_	NN	_	_	_	_	_
9	and	_	_	CC	_	_	_	_	_
10	left	_	_	VBN	_	_	_	_	_
11	ventricular	_	_	JJ	_	_	_	_	_
12	hypertrophy	_	_	NN	_	_	_	_	_
13	,	_	_	,	_	_	_	_	_
14	hypertension	_	_	NN	_	_	_	_	_
15	,	_	_	,	_	_	_	_	_
16	increased	_	_	VBN	_	_	_	_	_
17	arterial	_	_	JJ	_	_	_	_	_
18	stiffness	_	_	NN	_	_	_	_	_
19	,	_	_	,	_	_	_	_	_
20	and	_	_	CC	_	_	_	_	_
21	endothelial	_	_	JJ	_	_	_	_	_
22	dysfunction	_	_	NN	_	_	_	_	_
23	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	pathophysiological	_	_	JJ	_	_	_	_	_
3	underpinnings	_	_	NNS	_	_	_	_	_
4	of	_	_	IN	_	_	_	_	_
5	these	_	_	DT	_	_	_	_	_
6	associations	_	_	NNS	_	_	_	_	_
7	remain	_	_	VBP	_	_	_	_	_
8	mostly	_	_	RB	_	_	_	_	_
9	unexplained	_	_	JJ	_	_	_	_	_
10	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	most	_	_	RBS	_	_	_	_	_
3	reliable	_	_	JJ	_	_	_	_	_
4	and	_	_	CC	_	_	_	_	_
5	convincing	_	_	JJ	_	_	_	_	_
6	evidence	_	_	NN	_	_	_	_	_
7	for	_	_	IN	_	_	_	_	_
8	the	_	_	DT	_	_	_	_	_
9	involvement	_	_	NN	_	_	_	_	_
10	of	_	_	IN	_	_	_	_	_
11	vitamin	_	_	NN	_	_	_	_	_
12	D	_	_	NN	_	_	_	_	_
13	in	_	_	IN	_	_	_	_	_
14	the	_	_	DT	_	_	_	_	_
15	pathogenesis	_	_	NN	_	_	_	_	_
16	of	_	_	IN	_	_	_	_	_
17	CVD	_	_	NNP	_	_	_	_	_
18	comes	_	_	VBZ	_	_	_	_	_
19	from	_	_	IN	_	_	_	_	_
20	studies	_	_	NNS	_	_	_	_	_
21	demonstrating	_	_	VBG	_	_	_	_	_
22	an	_	_	DT	_	_	_	_	_
23	association	_	_	NN	_	_	_	_	_
24	between	_	_	IN	_	_	_	_	_
25	vitamin-D	_	_	NN	_	_	_	_	_
26	deficiency	_	_	NN	_	_	_	_	_
27	and	_	_	CC	_	_	_	_	_
28	hypertension	_	_	NN	_	_	_	_	_
29	.	_	_	.	_	_	_	_	_


1	Vitamin-D	_	_	NN	_	_	_	_	_
2	deficiency	_	_	NN	_	_	_	_	_
3	is	_	_	VBZ	_	_	_	_	_
4	associated	_	_	VBN	_	_	_	_	_
5	with	_	_	IN	_	_	_	_	_
6	a	_	_	DT	_	_	_	_	_
7	higher	_	_	JJR	_	_	_	_	_
8	risk	_	_	NN	_	_	_	_	_
9	for	_	_	IN	_	_	_	_	_
10	preeclampsia	_	_	NN	_	_	_	_	_
11	,	_	_	,	_	_	_	_	_
12	a	_	_	DT	_	_	_	_	_
13	condition	_	_	NN	_	_	_	_	_
14	that	_	_	WDT	_	_	_	_	_
15	is	_	_	VBZ	_	_	_	_	_
16	characterized	_	_	VBN	_	_	_	_	_
17	by	_	_	IN	_	_	_	_	_
18	hypertension	_	_	NN	_	_	_	_	_
19	.	_	_	.	_	_	_	_	_


1	Also	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	a	_	_	DT	_	_	_	_	_
4	significant	_	_	JJ	_	_	_	_	_
5	inverse	_	_	JJ	_	_	_	_	_
6	association	_	_	NN	_	_	_	_	_
7	was	_	_	VBD	_	_	_	_	_
8	reported	_	_	VBN	_	_	_	_	_
9	between	_	_	IN	_	_	_	_	_
10	vitamin-D	_	_	NN	_	_	_	_	_
11	serum	_	_	NN	_	_	_	_	_
12	levels	_	_	NNS	_	_	_	_	_
13	and	_	_	CC	_	_	_	_	_
14	arterial	_	_	JJ	_	_	_	_	_
15	blood	_	_	NN	_	_	_	_	_
16	pressure	_	_	NN	_	_	_	_	_
17	in	_	_	IN	_	_	_	_	_
18	the	_	_	DT	_	_	_	_	_
19	elderly	_	_	JJ	_	_	_	_	_
20	.	_	_	.	_	_	_	_	_


1	An	_	_	DT	_	_	_	_	_
2	interventional	_	_	JJ	_	_	_	_	_
3	study	_	_	NN	_	_	_	_	_
4	demonstrated	_	_	VBD	_	_	_	_	_
5	that	_	_	IN	_	_	_	_	_
6	one	_	_	CD	_	_	_	_	_
7	month	_	_	NN	_	_	_	_	_
8	of	_	_	IN	_	_	_	_	_
9	vitamin-D	_	_	NN	_	_	_	_	_
10	intake	_	_	NN	_	_	_	_	_
11	(	_	_	-LRB-	_	_	_	_	_
12	1,5000	_	_	CD	_	_	_	_	_
13	IU/day	_	_	NN	_	_	_	_	_
14	)	_	_	-RRB-	_	_	_	_	_
15	reduced	_	_	VBD	_	_	_	_	_
16	tissue	_	_	NN	_	_	_	_	_
17	sensitivity	_	_	NN	_	_	_	_	_
18	to	_	_	TO	_	_	_	_	_
19	the	_	_	DT	_	_	_	_	_
20	stimulation	_	_	NN	_	_	_	_	_
21	of	_	_	IN	_	_	_	_	_
22	the	_	_	DT	_	_	_	_	_
23	renin	_	_	NN	_	_	_	_	_
24	â€“	_	_	:	_	_	_	_	_
25	angiotensin	_	_	NN	_	_	_	_	_
26	system	_	_	NN	_	_	_	_	_
27	manifested	_	_	VBN	_	_	_	_	_
28	by	_	_	IN	_	_	_	_	_
29	improved	_	_	VBN	_	_	_	_	_
30	renal	_	_	JJ	_	_	_	_	_
31	blood	_	_	NN	_	_	_	_	_
32	flow	_	_	NN	_	_	_	_	_
33	and	_	_	CC	_	_	_	_	_
34	reduced	_	_	VBD	_	_	_	_	_
35	mean	_	_	JJ	_	_	_	_	_
36	arterial	_	_	JJ	_	_	_	_	_
37	pressure	_	_	NN	_	_	_	_	_
38	during	_	_	IN	_	_	_	_	_
39	an	_	_	DT	_	_	_	_	_
40	infusion	_	_	NN	_	_	_	_	_
41	of	_	_	IN	_	_	_	_	_
42	angiotensin	_	_	NN	_	_	_	_	_
43	II	_	_	CD	_	_	_	_	_
44	.	_	_	.	_	_	_	_	_


1	Moreover	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	vitamin-D	_	_	NN	_	_	_	_	_
4	intake	_	_	NN	_	_	_	_	_
5	(	_	_	-LRB-	_	_	_	_	_
6	2000	_	_	CD	_	_	_	_	_
7	IU/day	_	_	NN	_	_	_	_	_
8	)	_	_	-RRB-	_	_	_	_	_
9	for	_	_	IN	_	_	_	_	_
10	14	_	_	CD	_	_	_	_	_
11	days	_	_	NNS	_	_	_	_	_
12	in	_	_	IN	_	_	_	_	_
13	healthy	_	_	JJ	_	_	_	_	_
14	adults	_	_	NNS	_	_	_	_	_
15	reduced	_	_	VBD	_	_	_	_	_
16	augmentation	_	_	NN	_	_	_	_	_
17	index	_	_	NN	_	_	_	_	_
18	,	_	_	,	_	_	_	_	_
19	a	_	_	DT	_	_	_	_	_
20	measure	_	_	NN	_	_	_	_	_
21	of	_	_	IN	_	_	_	_	_
22	arterial	_	_	JJ	_	_	_	_	_
23	stiffness	_	_	NN	_	_	_	_	_
24	that	_	_	WDT	_	_	_	_	_
25	contributes	_	_	VBZ	_	_	_	_	_
26	to	_	_	TO	_	_	_	_	_
27	the	_	_	DT	_	_	_	_	_
28	development	_	_	NN	_	_	_	_	_
29	of	_	_	IN	_	_	_	_	_
30	hypertension	_	_	NN	_	_	_	_	_
31	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	discovery	_	_	NN	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	vitamin-D	_	_	NN	_	_	_	_	_
5	receptor	_	_	NN	_	_	_	_	_
6	(	_	_	-LRB-	_	_	_	_	_
7	VDR	_	_	NNP	_	_	_	_	_
8	)	_	_	-RRB-	_	_	_	_	_
9	widened	_	_	VBD	_	_	_	_	_
10	the	_	_	DT	_	_	_	_	_
11	scope	_	_	NN	_	_	_	_	_
12	of	_	_	IN	_	_	_	_	_
13	biological	_	_	JJ	_	_	_	_	_
14	effects	_	_	NNS	_	_	_	_	_
15	that	_	_	WDT	_	_	_	_	_
16	vitamin	_	_	NN	_	_	_	_	_
17	D	_	_	NN	_	_	_	_	_
18	plays	_	_	VBZ	_	_	_	_	_
19	in	_	_	IN	_	_	_	_	_
20	human	_	_	JJ	_	_	_	_	_
21	health	_	_	NN	_	_	_	_	_
22	.	_	_	.	_	_	_	_	_


1	VDR	_	_	NNP	_	_	_	_	_
2	is	_	_	VBZ	_	_	_	_	_
3	a	_	_	DT	_	_	_	_	_
4	transcription	_	_	NN	_	_	_	_	_
5	factor	_	_	NN	_	_	_	_	_
6	that	_	_	WDT	_	_	_	_	_
7	enters	_	_	VBZ	_	_	_	_	_
8	the	_	_	DT	_	_	_	_	_
9	nucleus	_	_	NN	_	_	_	_	_
10	upon	_	_	IN	_	_	_	_	_
11	binding	_	_	NN	_	_	_	_	_
12	to	_	_	TO	_	_	_	_	_
13	vitamin	_	_	NN	_	_	_	_	_
14	D	_	_	NNP	_	_	_	_	_
15	,	_	_	,	_	_	_	_	_
16	where	_	_	WRB	_	_	_	_	_
17	it	_	_	PRP	_	_	_	_	_
18	attaches	_	_	VBZ	_	_	_	_	_
19	to	_	_	TO	_	_	_	_	_
20	specific	_	_	JJ	_	_	_	_	_
21	DNA	_	_	NN	_	_	_	_	_
22	regions	_	_	NNS	_	_	_	_	_
23	and	_	_	CC	_	_	_	_	_
24	activates	_	_	VBZ	_	_	_	_	_
25	the	_	_	DT	_	_	_	_	_
26	transcription	_	_	NN	_	_	_	_	_
27	of	_	_	IN	_	_	_	_	_
28	a	_	_	DT	_	_	_	_	_
29	myriad	_	_	NN	_	_	_	_	_
30	of	_	_	IN	_	_	_	_	_
31	genes	_	_	NNS	_	_	_	_	_
32	that	_	_	WDT	_	_	_	_	_
33	coordinate	_	_	VBP	_	_	_	_	_
34	several	_	_	JJ	_	_	_	_	_
35	biological	_	_	JJ	_	_	_	_	_
36	responses	_	_	NNS	_	_	_	_	_
37	.	_	_	.	_	_	_	_	_


1	VDR	_	_	NNP	_	_	_	_	_
2	is	_	_	VBZ	_	_	_	_	_
3	widely	_	_	RB	_	_	_	_	_
4	expressed	_	_	VBN	_	_	_	_	_
5	throughout	_	_	IN	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	human	_	_	JJ	_	_	_	_	_
8	body	_	_	NN	_	_	_	_	_
9	in	_	_	IN	_	_	_	_	_
10	almost	_	_	RB	_	_	_	_	_
11	all	_	_	DT	_	_	_	_	_
12	cells	_	_	NNS	_	_	_	_	_
13	and	_	_	CC	_	_	_	_	_
14	tissues	_	_	NNS	_	_	_	_	_
15	,	_	_	,	_	_	_	_	_
16	including	_	_	VBG	_	_	_	_	_
17	vascular	_	_	JJ	_	_	_	_	_
18	smooth	_	_	JJ	_	_	_	_	_
19	muscle	_	_	NN	_	_	_	_	_
20	cells	_	_	NNS	_	_	_	_	_
21	,	_	_	,	_	_	_	_	_
22	cardiomyocytes	_	_	NNS	_	_	_	_	_
23	,	_	_	,	_	_	_	_	_
24	and	_	_	CC	_	_	_	_	_
25	endothelial	_	_	JJ	_	_	_	_	_
26	cells	_	_	NNS	_	_	_	_	_
27	.	_	_	.	_	_	_	_	_


1	Animal	_	_	NN	_	_	_	_	_
2	studies	_	_	NNS	_	_	_	_	_
3	found	_	_	VBD	_	_	_	_	_
4	that	_	_	IN	_	_	_	_	_
5	loss	_	_	NN	_	_	_	_	_
6	of	_	_	IN	_	_	_	_	_
7	VDR	_	_	NN	_	_	_	_	_
8	signaling	_	_	VBG	_	_	_	_	_
9	increased	_	_	VBD	_	_	_	_	_
10	arterial	_	_	JJ	_	_	_	_	_
11	stiffness	_	_	NN	_	_	_	_	_
12	and	_	_	CC	_	_	_	_	_
13	elevated	_	_	VBN	_	_	_	_	_
14	systolic	_	_	JJ	_	_	_	_	_
15	and	_	_	CC	_	_	_	_	_
16	diastolic	_	_	JJ	_	_	_	_	_
17	blood	_	_	NN	_	_	_	_	_
18	pressure	_	_	NN	_	_	_	_	_
19	,	_	_	,	_	_	_	_	_
20	independent	_	_	JJ	_	_	_	_	_
21	of	_	_	IN	_	_	_	_	_
22	the	_	_	DT	_	_	_	_	_
23	renin	_	_	NN	_	_	_	_	_
24	â€“	_	_	:	_	_	_	_	_
25	angiotensin	_	_	NN	_	_	_	_	_
26	â€“	_	_	:	_	_	_	_	_
27	aldosterone	_	_	NN	_	_	_	_	_
28	system	_	_	NN	_	_	_	_	_
29	.	_	_	.	_	_	_	_	_


1	Another	_	_	DT	_	_	_	_	_
2	study	_	_	NN	_	_	_	_	_
3	found	_	_	VBD	_	_	_	_	_
4	that	_	_	IN	_	_	_	_	_
5	VDR	_	_	NNP	_	_	_	_	_
6	knockout	_	_	NN	_	_	_	_	_
7	mice	_	_	NNS	_	_	_	_	_
8	have	_	_	VBP	_	_	_	_	_
9	increased	_	_	VBN	_	_	_	_	_
10	arterial	_	_	JJ	_	_	_	_	_
11	stiffness	_	_	NN	_	_	_	_	_
12	through	_	_	IN	_	_	_	_	_
13	decreased	_	_	VBN	_	_	_	_	_
14	bioavailability	_	_	NN	_	_	_	_	_
15	of	_	_	IN	_	_	_	_	_
16	nitric	_	_	NN	_	_	_	_	_
17	oxide	_	_	NN	_	_	_	_	_
18	(	_	_	-LRB-	_	_	_	_	_
19	NO	_	_	UH	_	_	_	_	_
20	)	_	_	-RRB-	_	_	_	_	_
21	.	_	_	.	_	_	_	_	_


1	These	_	_	DT	_	_	_	_	_
2	and	_	_	CC	_	_	_	_	_
3	other	_	_	JJ	_	_	_	_	_
4	studies	_	_	NNS	_	_	_	_	_
5	proposed	_	_	VBN	_	_	_	_	_
6	that	_	_	IN	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	leading	_	_	VBG	_	_	_	_	_
9	mechanism	_	_	NN	_	_	_	_	_
10	for	_	_	IN	_	_	_	_	_
11	the	_	_	DT	_	_	_	_	_
12	association	_	_	NN	_	_	_	_	_
13	between	_	_	IN	_	_	_	_	_
14	vitamin-D	_	_	NN	_	_	_	_	_
15	deficiency	_	_	NN	_	_	_	_	_
16	and	_	_	CC	_	_	_	_	_
17	CVD	_	_	NN	_	_	_	_	_
18	is	_	_	VBZ	_	_	_	_	_
19	related	_	_	VBN	_	_	_	_	_
20	to	_	_	TO	_	_	_	_	_
21	endothelial	_	_	JJ	_	_	_	_	_
22	dysfunction	_	_	NN	_	_	_	_	_
23	and	_	_	CC	_	_	_	_	_
24	impaired	_	_	VBN	_	_	_	_	_
25	endothelial-dependent	_	_	JJ	_	_	_	_	_
26	NO	_	_	DT	_	_	_	_	_
27	production	_	_	NN	_	_	_	_	_
28	.	_	_	.	_	_	_	_	_


1	Despite	_	_	IN	_	_	_	_	_
2	this	_	_	DT	_	_	_	_	_
3	accumulating	_	_	VBG	_	_	_	_	_
4	evidence	_	_	NN	_	_	_	_	_
5	of	_	_	IN	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	role	_	_	NN	_	_	_	_	_
8	of	_	_	IN	_	_	_	_	_
9	vitamin	_	_	NN	_	_	_	_	_
10	D	_	_	NN	_	_	_	_	_
11	in	_	_	IN	_	_	_	_	_
12	vascular	_	_	JJ	_	_	_	_	_
13	function	_	_	NN	_	_	_	_	_
14	,	_	_	,	_	_	_	_	_
15	direct	_	_	JJ	_	_	_	_	_
16	mechanistic	_	_	JJ	_	_	_	_	_
17	evidence	_	_	NN	_	_	_	_	_
18	of	_	_	IN	_	_	_	_	_
19	this	_	_	DT	_	_	_	_	_
20	role	_	_	NN	_	_	_	_	_
21	in	_	_	IN	_	_	_	_	_
22	the	_	_	DT	_	_	_	_	_
23	microvasculature	_	_	NN	_	_	_	_	_
24	of	_	_	IN	_	_	_	_	_
25	morbidly	_	_	RB	_	_	_	_	_
26	obese	_	_	JJ	_	_	_	_	_
27	population	_	_	NN	_	_	_	_	_
28	and	_	_	CC	_	_	_	_	_
29	how	_	_	WRB	_	_	_	_	_
30	it	_	_	PRP	_	_	_	_	_
31	might	_	_	MD	_	_	_	_	_
32	be	_	_	VB	_	_	_	_	_
33	modified	_	_	VBN	_	_	_	_	_
34	following	_	_	VBG	_	_	_	_	_
35	massive	_	_	JJ	_	_	_	_	_
36	weight	_	_	NN	_	_	_	_	_
37	loss	_	_	NN	_	_	_	_	_
38	are	_	_	VBP	_	_	_	_	_
39	largely	_	_	RB	_	_	_	_	_
40	unexplored	_	_	JJ	_	_	_	_	_
41	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	purpose	_	_	NN	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	the	_	_	DT	_	_	_	_	_
5	current	_	_	JJ	_	_	_	_	_
6	study	_	_	NN	_	_	_	_	_
7	is	_	_	VBZ	_	_	_	_	_
8	to	_	_	TO	_	_	_	_	_
9	investigate	_	_	VB	_	_	_	_	_
10	the	_	_	DT	_	_	_	_	_
11	effects	_	_	NNS	_	_	_	_	_
12	of	_	_	IN	_	_	_	_	_
13	vitamin	_	_	NN	_	_	_	_	_
14	D	_	_	NN	_	_	_	_	_
15	on	_	_	IN	_	_	_	_	_
16	the	_	_	DT	_	_	_	_	_
17	microvasculature	_	_	NN	_	_	_	_	_
18	isolated	_	_	VBN	_	_	_	_	_
19	from	_	_	IN	_	_	_	_	_
20	both	_	_	DT	_	_	_	_	_
21	subcutaneous	_	_	JJ	_	_	_	_	_
22	(	_	_	-LRB-	_	_	_	_	_
23	SAT	_	_	VBN	_	_	_	_	_
24	)	_	_	-RRB-	_	_	_	_	_
25	and	_	_	CC	_	_	_	_	_
26	visceral	_	_	JJ	_	_	_	_	_
27	adipose	_	_	NN	_	_	_	_	_
28	tissue	_	_	NN	_	_	_	_	_
29	(	_	_	-LRB-	_	_	_	_	_
30	VAT	_	_	NN	_	_	_	_	_
31	)	_	_	-RRB-	_	_	_	_	_
32	in	_	_	IN	_	_	_	_	_
33	morbidly	_	_	RB	_	_	_	_	_
34	obese	_	_	JJ	_	_	_	_	_
35	adults	_	_	NNS	_	_	_	_	_
36	before	_	_	IN	_	_	_	_	_
37	and	_	_	CC	_	_	_	_	_
38	after	_	_	IN	_	_	_	_	_
39	bariatric	_	_	JJ	_	_	_	_	_
40	surgery-induced	_	_	JJ	_	_	_	_	_
41	weight	_	_	NN	_	_	_	_	_
42	loss	_	_	NN	_	_	_	_	_
43	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	central	_	_	JJ	_	_	_	_	_
3	hypothesis	_	_	NN	_	_	_	_	_
4	is	_	_	VBZ	_	_	_	_	_
5	that	_	_	IN	_	_	_	_	_
6	vitamin	_	_	NN	_	_	_	_	_
7	D	_	_	NN	_	_	_	_	_
8	would	_	_	MD	_	_	_	_	_
9	improve	_	_	VB	_	_	_	_	_
10	microvascular	_	_	JJ	_	_	_	_	_
11	function	_	_	NN	_	_	_	_	_
12	in	_	_	IN	_	_	_	_	_
13	obese	_	_	JJ	_	_	_	_	_
14	adults	_	_	NNS	_	_	_	_	_
15	via	_	_	IN	_	_	_	_	_
16	improving	_	_	VBG	_	_	_	_	_
17	flow-mediated	_	_	JJ	_	_	_	_	_
18	NO	_	_	DT	_	_	_	_	_
19	production	_	_	NN	_	_	_	_	_
20	,	_	_	,	_	_	_	_	_
21	and	_	_	CC	_	_	_	_	_
22	this	_	_	DT	_	_	_	_	_
23	effect	_	_	NN	_	_	_	_	_
24	would	_	_	MD	_	_	_	_	_
25	be	_	_	VB	_	_	_	_	_
26	of	_	_	IN	_	_	_	_	_
27	a	_	_	DT	_	_	_	_	_
28	greater	_	_	JJR	_	_	_	_	_
29	magnitude	_	_	NN	_	_	_	_	_
30	before	_	_	IN	_	_	_	_	_
31	compared	_	_	VBN	_	_	_	_	_
32	to	_	_	TO	_	_	_	_	_
33	after	_	_	IN	_	_	_	_	_
34	weight	_	_	NN	_	_	_	_	_
35	loss	_	_	NN	_	_	_	_	_
36	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	our	_	_	PRP$	_	_	_	_	_
3	previous	_	_	JJ	_	_	_	_	_
4	work	_	_	NN	_	_	_	_	_
5	,	_	_	,	_	_	_	_	_
6	we	_	_	PRP	_	_	_	_	_
7	found	_	_	VBD	_	_	_	_	_
8	that	_	_	IN	_	_	_	_	_
9	flow-induced	_	_	JJ	_	_	_	_	_
10	dilation	_	_	NN	_	_	_	_	_
11	(	_	_	-LRB-	_	_	_	_	_
12	FID	_	_	NN	_	_	_	_	_
13	)	_	_	-RRB-	_	_	_	_	_
14	is	_	_	VBZ	_	_	_	_	_
15	impaired	_	_	VBN	_	_	_	_	_
16	in	_	_	IN	_	_	_	_	_
17	morbidly	_	_	RB	_	_	_	_	_
18	obese	_	_	JJ	_	_	_	_	_
19	individuals	_	_	NNS	_	_	_	_	_
20	due	_	_	JJ	_	_	_	_	_
21	to	_	_	TO	_	_	_	_	_
22	an	_	_	DT	_	_	_	_	_
23	imbalance	_	_	NN	_	_	_	_	_
24	of	_	_	IN	_	_	_	_	_
25	NO	_	_	NN	_	_	_	_	_
26	and	_	_	CC	_	_	_	_	_
27	H2O2	_	_	NNP	_	_	_	_	_
28	.	_	_	.	_	_	_	_	_


1	H2O2	_	_	NNP	_	_	_	_	_
2	may	_	_	MD	_	_	_	_	_
3	serve	_	_	VB	_	_	_	_	_
4	as	_	_	IN	_	_	_	_	_
5	a	_	_	DT	_	_	_	_	_
6	compensatory	_	_	JJ	_	_	_	_	_
7	mechanism	_	_	NN	_	_	_	_	_
8	for	_	_	IN	_	_	_	_	_
9	vasodilation	_	_	NN	_	_	_	_	_
10	during	_	_	IN	_	_	_	_	_
11	pathological	_	_	JJ	_	_	_	_	_
12	conditions	_	_	NNS	_	_	_	_	_
13	such	_	_	JJ	_	_	_	_	_
14	as	_	_	IN	_	_	_	_	_
15	obesity	_	_	NN	_	_	_	_	_
16	.	_	_	.	_	_	_	_	_


1	Using	_	_	VBG	_	_	_	_	_
2	the	_	_	DT	_	_	_	_	_
3	proposed	_	_	VBN	_	_	_	_	_
4	ex	_	_	NNP	_	_	_	_	_
5	vivo	_	_	NN	_	_	_	_	_
6	system	_	_	NN	_	_	_	_	_
7	in	_	_	IN	_	_	_	_	_
8	this	_	_	DT	_	_	_	_	_
9	study	_	_	NN	_	_	_	_	_
10	,	_	_	,	_	_	_	_	_
11	we	_	_	PRP	_	_	_	_	_
12	are	_	_	VBP	_	_	_	_	_
13	able	_	_	JJ	_	_	_	_	_
14	to	_	_	TO	_	_	_	_	_
15	explore	_	_	VB	_	_	_	_	_
16	the	_	_	DT	_	_	_	_	_
17	contributing	_	_	VBG	_	_	_	_	_
18	vasoactive	_	_	JJ	_	_	_	_	_
19	mediators	_	_	NNS	_	_	_	_	_
20	of	_	_	IN	_	_	_	_	_
21	vitamin-D	_	_	NN	_	_	_	_	_
22	effects	_	_	NNS	_	_	_	_	_
23	on	_	_	IN	_	_	_	_	_
24	microvascular	_	_	JJ	_	_	_	_	_
25	function	_	_	NN	_	_	_	_	_
26	,	_	_	,	_	_	_	_	_
27	mainly	_	_	RB	_	_	_	_	_
28	NO	_	_	NNP	_	_	_	_	_
29	and	_	_	CC	_	_	_	_	_
30	H2O2	_	_	NNP	_	_	_	_	_
31	.	_	_	.	_	_	_	_	_

